Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brett Case

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Cell|March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domainWanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell Reports|December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Cell|March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domainWanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell Reports|December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 9